In this study, the authors used the SOD1-G93A mice (a well-established model of ALS that closely resembles the clinical features of the disease) and performed in vivo blockade of P2X7, by using the blood-brain barrier permeable and safe P2X7 antagonist Brilliant Blue G (BBG). Here, P2RX7 is linked to amyotrophic lateral sclerosis.